<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34316551</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Cognitive deficits in people who have recovered from COVID-19.</ArticleTitle><Pagination><StartPage>101044</StartPage><MedlinePgn>101044</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101044</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2021.101044</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is growing concern about possible cognitive consequences of COVID-19, with reports of 'Long COVID' symptoms persisting into the chronic phase and case studies revealing neurological problems in severely affected patients. However, there is little information regarding the nature and broader prevalence of cognitive problems post-infection or across the full spread of disease severity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We sought to confirm whether there was an association between cross-sectional cognitive performance data from 81,337 participants who between January and December 2020 undertook a clinically validated web-optimized assessment as part of the Great British Intelligence Test, and questionnaire items capturing self-report of suspected and confirmed COVID-19 infection and respiratory symptoms.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">People who had recovered from COVID-19, including those no longer reporting symptoms, exhibited significant cognitive deficits versus controls when controlling for age, gender, education level, income, racial-ethnic group, pre-existing medical disorders, tiredness, depression and anxiety. The deficits were of substantial effect size for people who had been hospitalised (<i>N</i>&#xa0;=&#xa0;192), but also for non-hospitalised cases who had biological confirmation of COVID-19 infection (<i>N</i>&#xa0;=&#xa0;326). Analysing markers of premorbid intelligence did not support these differences being present prior to infection. Finer grained analysis of performance across sub-tests supported the hypothesis that COVID-19 has a multi-domain impact on human cognition.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Interpretation. These results accord with reports of 'Long Covid' cognitive symptoms that persist into the early-chronic phase. They should act as a clarion call for further research with longitudinal and neuroimaging cohorts to plot recovery trajectories and identify the biological basis of cognitive deficits in SARS-COV-2 survivors.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Funding. AH is supported by the UK Dementia Research Institute Care Research and Technology Centre and Biomedical Research Centre at Imperial College London. WT is supported by the EPSRC Centre for Doctoral Training in Neurotechnology. SRC is funded by a Wellcome Trust Clinical Fellowship 110,049/Z/15/Z. JMB is supported by Medical Research Council (MR/N013700/1). MAM, SCRW and PJH are, in part, supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London.</AbstractText><CopyrightInformation>&#xa9; 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hampshire</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Brain Sciences, Dementia Research Institute Care Research and Technology Centre, Imperial College London, 926, Sir Michael Uren Hub 86 Wood Lane, London, W12 0BZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trender</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Brain Sciences, Dementia Research Institute Care Research and Technology Centre, Imperial College London, 926, Sir Michael Uren Hub 86 Wood Lane, London, W12 0BZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chamberlain</LastName><ForeName>Samuel R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jolly</LastName><ForeName>Amy E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Brain Sciences, Dementia Research Institute Care Research and Technology Centre, Imperial College London, 926, Sir Michael Uren Hub 86 Wood Lane, London, W12 0BZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Jon E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Chicago, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patrick</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazibuko</LastName><ForeName>Ndaba</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Steve Cr</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnby</LastName><ForeName>Joseph M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellyer</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Brain Sciences, Dementia Research Institute Care Research and Technology Centre, Imperial College London, 926, Sir Michael Uren Hub 86 Wood Lane, London, W12 0BZ.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Mitul A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Attention</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Deficits</Keyword><Keyword MajorTopicYN="N">Long covid</Keyword><Keyword MajorTopicYN="N">Memory</Keyword><Keyword MajorTopicYN="N">Online assessment</Keyword><Keyword MajorTopicYN="N">Planning</Keyword><Keyword MajorTopicYN="N">Reasoning</Keyword></KeywordList><CoiStatement>Dr. Hampshire reports grants from UK Dementia Research Institute, outside the submitted work and is Co-director and owner of H2CD Ltd, and owner and director of Future Cognition Ltd, which support online studies and develop custom cognitive assessment software respectively. Dr. Hellyer reports personal fees from H2CD Ltd, outside the submitted work. Dr. Chamberlain reports grants from Wellcome, personal fees from Elsevier, personal fees from Prometis (not current), outside the submitted work. Dr. Grant reports grants from Otsuka, grants from Biohaven, grants from Avanir, outside the submitted work. Dr. Patrick reports grants from H Lundbeck A/S, non-financial support from Astra Zeneca, non-financial support from Janssen, outside the submitted work. Dr. Mehta reports grants from H Lundbeck A/S, non-financial support from Astra Zeneca, non-financial support from Janssen, outside the submitted work. Dr. Williams has nothing to disclose. Dr. Mazibuko has nothing to disclose. Dr. Jolly has nothing to disclose. Mr. Trender has nothing to declare. Dr. Barnby has nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34316551</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pii">S2589-5370(21)00324-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baig A.M. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E., Callard F., Stras L., Melville-J&#xf3;hannesson B., Pope R., Alwan N.A. Wellcome Open Research; 2020. Why the patient-made term 'long Covid' is needed.</Citation></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M.A., Benjamin L., Singh B. Neurological associations of COVID-19. Lancet Neurol. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M., Varatharaj A., Nicholson T.R. Defining causality in COVID-19 and neurological disorders. J Neurol Neurosurg Psychiatry. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299654</ArticleId><ArticleId IdType="pubmed">32503883</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson R.W., Brown R.L., Benjamin L. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyrouti R., Adams M.E., Benjamin L. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7231545</ArticleId><ArticleId IdType="pubmed">32354768</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>von Weyhern C.H., Kaufmann I., Neff F., Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. 2020;395(10241):e109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272176</ArticleId><ArticleId IdType="pubmed">32505222</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G., Palmerini F., Ravaglia S. Guillain-barre syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574&#x2013;2576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention. JAMA. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., Ferse C., Kreye J. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021;93:415&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., de Seze J. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin L., Saraceno G., Panciani P.P. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 2020;162(7):1491&#x2013;1494. (Wien)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197630</ArticleId><ArticleId IdType="pubmed">32367205</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown E., Gray R., Lo Monaco S. The potential impact of COVID-19 on psychosis: a rapid review of contemporary epidemic and pandemic research. Schizophr Res. 2020;222:79&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200363</ArticleId><ArticleId IdType="pubmed">32389615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasannejad C., Ely E.W., Lahiri S. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care. 2019;23(1):352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6852966</ArticleId><ArticleId IdType="pubmed">31718695</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowkwanyun M., Reed A.L. Racial health disparities and COVID-19-caution and context. N Engl J Med. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32374952</ArticleId></ArticleIdList></Reference><Reference><Citation>P.H England.. Disparities in the risk and outcomes of COVID-19., 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby T. Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities. Lancet Respir Med. 2020;8(6):547&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211498</ArticleId><ArticleId IdType="pubmed">32401711</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A. Research Square; 2020. Great british intelligence test protocol.</Citation></Reference><Reference><Citation>Chamberlain S.R., Grant J.E., Trender W., Hellyer P., Hampshire A. Post-traumatic stress disorder symptoms in COVID-19 survivors: online population survey. BJPsych Open. 2021;7(2):e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873456</ArticleId><ArticleId IdType="pubmed">33557964</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Hellyer P.J., Soreq E. Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom. Nat Commun. 2021;12(1):4111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285408</ArticleId><ArticleId IdType="pubmed">34272365</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurn B., Starr J.M., Topfer J.A. Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation. Neurology. 2004;62(7):1184&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pubmed">15079021</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Highfield R.R., Parkin B.L., Owen A.M. Fractionating human intelligence. Neuron. 2012;76(6):1225&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pubmed">23259956</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolly A.E., Scott G.T., Sharp D.J., Hampshire A. Distinct patterns of structural damage underlie working memory and reasoning deficits after traumatic brain injury. Brain. 2020;143(4):1158&#x2013;1176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7174032</ArticleId><ArticleId IdType="pubmed">32243506</ArticleId></ArticleIdList></Reference><Reference><Citation>Soreq E., Violante I.R., Daws R.E., Hampshire A. Neuroimaging evidence for a network sampling theory of individual differences in human intelligence test performance. Nat Commun. 2021;12(1):2072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8024400</ArticleId><ArticleId IdType="pubmed">33824305</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.P. Twenty-five years of research on the behavioural malaise associated with influenza and the common cold. Psychoneuroendocrinology. 2013;38(6):744&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7130811</ArticleId><ArticleId IdType="pubmed">23021498</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E.A., O'Connor R.C., Perry V.H. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159850</ArticleId><ArticleId IdType="pubmed">32304649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>